CVRFSoCal

166 posts

CVRFSoCal banner
CVRFSoCal

CVRFSoCal

@CVRF_SoCal

Nonprofit advancing heart care through research, education, phallanthrolpy and imaging. Based in Beverly Hills. Research arm of Cardiovascular

Beigetreten Mayıs 2025
124 Folgt144 Follower
CVRFSoCal retweetet
Ronald P. Karlsberg MD FACP FAHA FACC MSCCT |
Thank you for stepping up and addressing misinformation that directly harms patients and creates confusion. The solution is simple—ask for the data that supports the claims. We all need to push back and move the needle against this constant noise, much of which is driven by self-promotion rather than evidence.
English
5
2
3
386
CVRFSoCal retweetet
ⁿᵉʷˢ Robert F. Kennedy Jr.
ⁿᵉʷˢ Robert F. Kennedy Jr.@RobertKennedyJc·
Is your belt sized getting bigger? Obesity isn’t just a look. It’s a warning sign. It’s the gateway to Type 2 diabetes, Hypertension, Nonalcoholic fatty liver disease, Insulin resistance, & even Cancer. We normalize it, ignore it, & then wonder why we’re getting sicker. MAHA
English
23
29
208
6.5K
CVRFSoCal
CVRFSoCal@CVRF_SoCal·
@ElucidBio The Cardiovascular Research Foundation of Southern California is proud to be a participant in this publication
English
0
0
1
7
Elucid
Elucid@ElucidBio·
A new JACC Journals: Case Reports publication highlights an important reality in #cardiovascularcare: high-risk coronary disease can be clinically silent. In this case, advanced coronary CT imaging revealed extensive plaque dominated by lipid-rich necrotic core (#LRNC), a key marker of vulnerable plaque and future coronary events. Read here: sciencedirect.com/science/articl… Key takeaways: • Severe coronary disease may exist without symptoms, underscoring the limits of symptom-based detection • LRNC is a critical marker of plaque vulnerability and future risk • Advanced coronary imaging can reveal hidden disease earlier, enabling more proactive management Studies like this reinforce the importance of detecting true disease earlier—before heart attack or stroke occurs. Congrats to the authors! Drs. @elisarrarasx, Robert Pelberg, Jacob S. Roberts, @JayShah_MD, Jeffrey Xia, Sammy Sayed, Norman Lepor, Jairo Aldana-Bitar, @RonKarlsbergMD, Geoffrey Cho #Cardiology #CCTA #CoronaryPlaque #PreventiveCardiology #CardiovascularImaging #CAD
Elucid tweet media
English
1
0
1
121
CVRFSoCal retweetet
Heart_SCCT
Heart_SCCT@Heart_SCCT·
Join us for the CTA Academy: Coronary CTA Workshop on April 11-12, 2026! Enhance your skills with hands-on learning from experts. Don’t miss out on tackling complex cases! @ToddVillinesMD @AmitPursnaniMD Register: ow.ly/CBuE50YlZaG
Heart_SCCT tweet media
English
0
4
15
778
Ronald P. Karlsberg MD FACP FAHA FACC MSCCT |
Over the past two decades, we have finally reached the threshold where coronary CTA is not only mainstream, but central to mitigating and treating the disease and making a major impact on our number one killer. The SCCT has methodically and persistently moved to place coronary CTA at the center of the evidence base, and we are proud and humbled to be part of that process. #cardiology @DLBHATTMD @DrMarthaGulati @ToddVillinesMD
English
1
2
7
818
CVRFSoCal
CVRFSoCal@CVRF_SoCal·
RT @RonKarlsbergMD: 🚀 New research in Nature Medicine from Stanford shows that large language models (LLMs) can meaningfully boost clinical…
English
0
1
0
3
CVRFSoCal
CVRFSoCal@CVRF_SoCal·
@RonKarlsbergMD This is only the beginning. The way we deliver and provide medicine will need to be completely rebuilt. The integration of AI at the "point of care" is a turning point in healthcare — one of the greatest opportunities to transform medicine for the better.
English
0
0
1
11
CVRFSoCal retweetet
Ronald P. Karlsberg MD FACP FAHA FACC MSCCT |
Respectfully, the comments are misleading and should be clarified so that we properly present the data and inform the public with accuracy. Large randomized trial meta-analyses show statins do slightly increase new-onset diabetes risk (about 9–12% relative increase), but the absolute risk is small—roughly ~1 extra case per ~250 people treated for ~4 years, and it occurs mostly in people who already have underlying diabetes risk factors (prediabetes, obesity, metabolic syndrome). In other words, statins tend to accelerate diabetes in those predisposed, rather than “cause” it out of nowhere. But still there is a value proposition. Muscle symptoms are reported, but blinded trials show much of the muscle pain signal is also seen on placebo, and serious muscle injury is rare. Meanwhile, statins prevent far more harm—often ~1 major cardiovascular event prevented per ~25–50 treated over ~5 years, depending on baseline risk. So yes, risk is real and already in labeling, but the overall benefit/risk profile remains strongly favorable for most higher-risk patients. Lets keep the discussion fair.
English
3
2
29
1K
CVRFSoCal retweetet
Ronald P. Karlsberg MD FACP FAHA FACC MSCCT |
@chrisboettcher9 Respectfully, to protect the public space: CAC scoring is a legitimate, guideline-supported risk marker, but it does not directly show “how clogged your arteries are” (it measures calcified plaque burden, not total plaque or degree of blockage). And the claim that one should take
English
2
2
18
1.3K
CVRFSoCal retweetet
Dr. John A Rumberger, PhD, MD, FACC, MSCCT
I learned today that my dear friend and colleague Dr Harvey Hecht passed On January 28. Harvey was a pioneer in CAC and CCTA and was the first president of the society of cardiovascular imaging and a leading preventive cardiologist long before such a profession was fully realized
English
3
4
12
965